Oral tazarotene improves quality of life

April 1, 2004

Washington - A new study shows that oral tazarotene (Tazorac; Allergan Inc., Irvine,Calif.) provides significant improvements in quality of life for sufferers of plaque psoriasis. The same study also illustrates the validity of a new measuring tool, PQOL (Psoriasis Quality of Life)-12, for measuring the disease's severity (see related article on Page 35).